During the last session, Organigram Global Inc (NASDAQ:OGI)’s traded shares were 0.77 million, with the beta value of the company hitting 1.45. At the end of the trading day, the stock’s price was $1.45, reflecting an intraday loss of -1.36% or -$0.02. The 52-week high for the OGI share is $2.08, that puts it down -43.45 from that peak though still a striking 41.38% gain since the share price plummeted to a 52-week low of $0.85. The company’s market capitalization is $194.13M, and the average intraday trading volume over the past 10 days was 0.6 million shares, and the average trade volume was 545.91K shares over the past three months.
Organigram Global Inc (OGI) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.40. OGI has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.01.
Organigram Global Inc (NASDAQ:OGI) trade information
Organigram Global Inc (OGI) registered a -1.36% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.36% in intraday trading to $1.45, hitting a weekly high. The stock’s 5-day price performance is 1.40%, and it has moved by 1.40% in 30 days. Based on these gigs, the overall price performance for the year is -9.94%. The short interest in Organigram Global Inc (NASDAQ:OGI) is 6.09 million shares and it means that shorts have 9.72 day(s) to cover.
Organigram Global Inc (OGI) estimates and forecasts
In the rating firms’ projections, revenue will increase 54.35% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 68.04M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 69.46M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 41.06M and 44.7M respectively. In this case, analysts expect current quarter sales to grow by 65.72% and then jump by 55.39% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -11.39%. While earnings are projected to return 136.34% in 2025.
OGI Dividends
Organigram Global Inc is due to release its next quarterly earnings on 2025-May-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Organigram Global Inc (NASDAQ:OGI)’s Major holders
Organigram Global Inc insiders own 32.41% of total outstanding shares while institutional holders control 5.59%, with the float percentage being 8.27%. TOROSO INVESTMENTS, LLC is the largest shareholder of the company, while 80.0 institutions own stock in it. As of 2024-06-30, the company held over 1.8 million shares (or 1.7331% of all shares), a total value of $2.77 million in shares.
The next largest institutional holding, with 1.0 million shares, is of ADVISORSHARES INVESTMENTS LLC’s that is approximately 0.9635% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.54 million.
Also, the Mutual Funds coming in first place with the largest holdings of Organigram Global Inc (OGI) shares are Amplify ETF Trust-Amplify Alternative Harvest ETF and AdvisorShares Trust-AdvisorShares Pure Cannabis ETF . Data provided on Mar 31, 2025 indicates that Amplify ETF Trust-Amplify Alternative Harvest ETF owns about 2.35 shares. This amounts to just over 1.75 percent of the company’s overall shares, with a $3.41 million market value. The same data shows that the other fund manager holds slightly less at 903.85, or about 0.67% of the stock, which is worth about $1.31 million.
